Yi Xiang, Batrakova Elena, Banks William A, Vinogradov Serguei, Kabanov Alexander V
Department of Pharmaceutical Sciences and Center for Drug Delivery and Nanomedicine, College of Pharmacy, University of Nebraska Medical Center, Omaha, Nebraska 68198-5830, USA.
Bioconjug Chem. 2008 May;19(5):1071-7. doi: 10.1021/bc700443k. Epub 2008 Apr 16.
Modification of a model protein, horseradish peroxidase (HRP), with amphiphilic block copolymer poly(ethylene oxide)-b-poly(propylene oxide)-b-poly(ethylene oxide) (Pluronic), was previously shown to enhance the transport of this protein across the blood-brain barrier in vivo and brain microvessel endothelial cells in vitro. This work develops procedures for synthesis and characterization of HRP with Pluronic copolymers, having different lengths of poly(ethylene oxide) (PEO) and poly(propylene oxide) (PPO) blocks. Four monoamine Pluronic derivatives (L81, P85, L121, P123) were synthesized and successfully conjugated to a model protein, HRP, via biodegradable or nondegradable linkers (dithiobis(succinimidyl propionate) (DSP), dimethyl 3,3'-dithiobispropionimidate (DTBP), and disuccinimidyl propionate (DSS)). The conjugation was confirmed by HRP amino group titration, matrix-assisted laser desorption/ionization-time of flight spectroscopy, and cation-exchange chromatography. HRP conjugates containing an average of one to two Pluronic moieties and retaining in most cases over 70% of the activity were synthesized. Increased cellular uptake of these conjugates was demonstrated using the Mardin-Derby canine kidney cell line and primary bovine brain microvessel endothelial cells. The optimal modifications included Pluronic L81 and P85. These copolymers have shorter PPO chains compared to Pluronic P123 and L121, which were less efficient. There was little if any dependence of the uptake on the length of the hydrophilic PEO block for the optimal modifications. The proposed modifications may be used to increase cellular uptake of other proteins.
先前研究表明,用两亲性嵌段共聚物聚(环氧乙烷)-b-聚(环氧丙烷)-b-聚(环氧乙烷)(普朗尼克)修饰模型蛋白辣根过氧化物酶(HRP),可增强该蛋白在体内穿过血脑屏障以及在体外穿过脑微血管内皮细胞的转运能力。本研究开发了用具有不同聚(环氧乙烷)(PEO)和聚(环氧丙烷)(PPO)嵌段长度的普朗尼克共聚物合成及表征HRP的方法。合成了四种单胺普朗尼克衍生物(L81、P85、L121、P123),并通过可生物降解或不可生物降解的连接子(二硫代双(琥珀酰亚胺丙酸酯)(DSP)、二甲基3,3'-二硫代双丙酰亚胺(DTBP)和琥珀酰亚胺丙酸酯(DSS))成功将其与模型蛋白HRP偶联。通过HRP氨基滴定、基质辅助激光解吸/电离飞行时间光谱和阳离子交换色谱法确认了偶联。合成了平均含有一到两个普朗尼克部分且在大多数情况下保留超过70%活性的HRP偶联物。使用马汀-德比犬肾细胞系和原代牛脑微血管内皮细胞证明了这些偶联物的细胞摄取增加。最佳修饰包括普朗尼克L81和P85。与效率较低的普朗尼克P123和L121相比,这些共聚物具有较短的PPO链。对于最佳修饰,摄取几乎不依赖于亲水性PEO嵌段的长度。所提出的修饰可用于增加其他蛋白质的细胞摄取。